TD Cowen raised the firm’s price target on Calumet Specialty Products to $23 from $21 and keeps an Outperform rating on the shares. The analyst said its biofuel project is arguably in the most critical phase with the pre-treatment unit ramp and its expansion case presents additional upside.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CLMT:
- Calumet Specialty Products Partners, L.P. Reports Fourth Quarter and Full Year 2022 Results
- Calumet Specialty Products reports Q4 EPS (86c), consensus 0c
- Darling Ingredients target raised to $115, added to ‘Select List’ at Stifel
- Calumet Specialty price target lowered to $25 from $28 at H.C. Wainwright
- Wells Fargo, Disney among stocks watched by value investors, Barron’s says
